And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been ...

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

The firm will use its blood-based tests to explore connections between Alzheimer's disease and neuronal α-synuclein conditions including Parkinson's disease.

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...

Dementia is commonly viewed as a condition that affects older adults, but mounting evidence reveals that it is not just a ...

Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...

“Even in individuals who had not yet developed kidney disease, we could see that kidney function was linked to brain atrophy.

Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on LNTH stock, giving a Buy rating yesterday.Stay Ahead of the ...

Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LNTH stock, giving a Buy rating yesterday.Stay Ahead of the ...

A new study reveals that over 75% of older adults with dementia may not know they have the disease, with awareness rates even ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.